ABBOTT INDIA
Back to Cashflow Statement
|
ABBOTT INDIA Last 5 Year Cash Flow from Financing Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹-925 Cr | ₹-745 Cr | ₹-639 Cr | ₹-637 Cr | ₹-582 Cr |
What is the latest Cash Flow from Financing Activities ratio of ABBOTT INDIA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-925 Cr |
| Mar2024 | ₹-745 Cr |
| Mar2023 | ₹-639 Cr |
| Mar2022 | ₹-637 Cr |
| Mar2021 | ₹-582 Cr |
How is Cash Flow from Financing Activities of ABBOTT INDIA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-925 Cr | Negative | |
| Mar2024 | ₹-745 Cr | Negative | |
| Mar2023 | ₹-639 Cr | Negative | |
| Mar2022 | ₹-637 Cr | Negative | |
| Mar2021 | ₹-582 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹56,629.7 Cr | 4.5% | 2.7% | -24.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,593.0 Cr | 2% | 6.7% | 14.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,737.0 Cr | 3.5% | 2.2% | 0.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹164,290.0 Cr | 4.6% | 9.9% | 41.5% | Stock Analytics | |
| CIPLA | ₹117,327.0 Cr | -0.3% | 3.7% | -2.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹112,994.0 Cr | 1.1% | 5.9% | 6.6% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 4.5% |
2.7% |
-24.7% |
| SENSEX | 2.2% |
5.1% |
-7% |
You may also like the below Video Courses